Talis Biomedical Corp - TLIS Net earnings per share for the last 12 months

Public company logo of Talis Biomedical Corp. (TLIS)

The absence of geopolitical risks and trade tariffs is driving the expansion of Talis Biomedical (TLIS), as confirmed by the annual EPS (TTM) growth statistics. The value 24.90 determines this parameter level. The business foundation relies on the sale of disposable cartridges for rapid analyzers, although current cash flows remain volatile due to the stage of integrating diagnostic systems into clinical standards.

Talis Biomedical Corporation - TLIS Earnings per share for the last twelve months (period 02/11/2024 - 02/20/2024)

Talis Biomedical Corp - analytical breakdowns and key metrics (TLIS)

- market price and analyst price targets:
Market Chart Talis Biomedical|TLIS - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Talis Biomedical Corp.|TLIS - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Talis Biomedical|TLIS - Company Book Value|Market Cap to Net Assets Ratio talis.bio|TLIS - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Talis Biomedical|TLIS - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Talis Biomedical|TLIS - Company Aggregate Debts|Debts to Net Assets Talis Biomedical Corp.|TLIS - Company Long-Term Debts|Company Current Liabilities Talis Biomedical|Quick Ratio talis.bio
- financial results and valuation multiples details:
TLIS - Company Net Income|Expected Profit Talis Biomedical|TLIS - Price to Earnings Ratio|Future Price to Earnings Multiple Talis Biomedical|TLIS - PEG Multiple|Company Value to EBITDA Talis Biomedical Corp.|TLIS - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Talis Biomedical|TLIS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth talis.bio|TLIS - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Talis Biomedical
Fundamental company valuation:TLIS (Talis Biomedical Corporation)
Core merchandise of Talis Biomedical Corporation

Talis Biomedical (TLIS) is currently focused on an orderly wind-down of operations and the return of capital to shareholders in accordance with SEC regulations. The analyzed metric measures the rolling year earnings per share (EPS) trend, converting financial statements into a daily trajectory. This helps investors identify market imbalances and avoid purchasing the asset at its peak. In a liquidation scenario, the year-over-year (YoY) growth in net income per share over the last 12 months serves as an indicator of the efficiency of residual asset distribution. Extreme peaks on this chart may signal that the potential for value growth has been exhausted.

Competitor analysis for Talis Biomedical

Net earnings per share for the last four quarters abbott.com ABT|TMO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GE HealthCare Technologies Inc.|Net earnings per share for the last 12 months MTD|WAT: Earnings per share for the trailing year|Earnings per share for the last twelve months Bio-Techne Corporation (TECH)|Net earnings per share for the last 12 months bruker.com BRKR|Net earnings per share (EPS TTM) AZTA (Azenta)|Varex Imaging Corp (VREX) - Net earnings per one share for the last twelve months|Semler Scientific Corp - Net earnings per share (EPS TTM)|BFLY (Butterfly Corp) - Earnings per share for the last 12 months|MLAB: Net earnings per share (EPS TTM)|QSI - Net earnings per share for the last four quarters|NNOX (Nano-X) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quanterix Corp. (QTRX)|Net earnings per share (EPS TTM) MASS|Net earnings per share (EPS TTM) capsovision.com (CV)|Earnings per share for the last twelve months MaxCyte, Inc. MXCT|Rapid Micro Biosystems Inc. - Earnings per share for the last twelve months|SEER: Net earnings per share for the last 12 months|Earnings per share for the trailing year HYPR (Hyperfine Inc)|FONR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Daxor (DXR)|Earnings per share for the last twelve months Spectral AI, Inc.|VIVS - Net earnings per share for the trailing year|Net earnings per share for the last 12 months ACON (Aclarion, Inc.)|Net earnings per share (EPS TTM) akoyabio.com (AKYA)|Net earnings per share (EPS TTM) THMO (ThermoGenesis Holdings Inc.)|Net earnings per share for the last four quarters T2 Biosystems Inc (TTOO)